Filing Flows › BioStem Technologies (BSEM) › Q2 2026 › vs Q2 2025
BioStem Technologies (BSEM) Q2 2026 vs Q2 2025 (year over year)
BioStem Technologies's revenue fell $3.1M (-28%) from $11.0M in Q2 2025 to $7.9M in Q2 2026. The biggest changes: Physician Office −$9.9M (-90%); Hospital +$6.7M (—); Other +$89K (—).
BioStem Technologies, Q2 2026: revenue $7.9M (-28% year over year), operating margin -106.3%, net loss $9.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Hospital | $6.7M | $0 | $6.7M | — |
| Physician Office | $1.1M | $11.0M | −$9.9M | -90% |
| Other | $89K | $0 | $89K | — |
| Revenue | $7.9M | $11.0M | −$3.1M | -28% |
| Net loss | $9.0M | −$11K | $9.0M | — |
| Costs & expenses | $16.9M | $11.0M | $5.8M | +53% |
| Operating costs | $16.3M | $10.9M | $5.4M | +50% |
| Interest & other, net | $571K | −$65K | $636K | — |
| Cost of revenue | $3.1M | $685K | $2.4M | +346% |
| Research & development | $734K | $2.0M | −$1.2M | -63% |
| Sales & marketing | $5.3M | $1.3M | $4.0M | +317% |
| General & admin | $6.5M | $6.9M | −$375K | -5% |
| Other operating costs | $689K | $61K | $629K | 11× |
Questions
How much did BioStem Technologies's revenue grow year over year in Q2 2026?
BioStem Technologies's revenue fell $3.1M (-28%) from $11.0M in Q2 2025 to $7.9M in Q2 2026.
What drove BioStem Technologies's revenue change in Q2 2026?
Physician Office −$9.9M (-90%); Hospital +$6.7M (—); Other +$89K (—).